can you believe that, i do
i dont but some have sugggested that
wallstreet must have no confidence in isonep
looks like pfizer might want this biotech on the cheap seeeing it doesnt deliver on both groups
its only money and to be honest i dont think isonep is going to fail.
well i think vicals vaccine which results are due out shortly could be the leader in the herpes vaccine race especially using vaxfection
what did you get when they said there going to the occular conference in november. how do they know the isonep data is going to be that good. what if the data is bad. they should have never teased there investors about going to the conference in november. v j samant did the same thing with vical reguarding the allovectin7 results and the investors thought they had leak information about allovectin7 and the results didnt meet the endpoint. then vical was hit with a class action lawsuit. i just wish this would get over with. sink or swim